Peter W Bushunow MD

Oncology•Rochester, NY

Physician

Join to View Full Profile

1425 Portland AveRochester, NY 14621
Phone+1 585-922-4200
Fax+1 585-922-4622

Education & Training

SUNY Upstate Medical UniversityFellowship, Hematology and Medical Oncology, 1989 - 1992
SUNY Upstate Medical UniversityResidency, Internal Medicine, 1986 - 1989
Washington University in St. Louis School of MedicineClass of 1986

Certifications & Licensure

NY State Medical License 1987 - 2026
CA State Medical License 2023 - 2025
American Board of Internal Medicine Internal Medicine

Clinical Trials

Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas Start of enrollment: 2000 Jun 01
Completed
Phase 3
Buspirone in Reducing Shortness of Breath in Patients With Cancer Start of enrollment: 2002 Nov 01
Completed
Phase 2, Phase 3
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) Start of enrollment: 2006 Apr 07
ACTIVE_NOT_RECRUITING
PHASE3
Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer Start of enrollment: 2009 Nov 01
Terminated
Phase 2
Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer Start of enrollment: 2010 Feb 01
Terminated
Phase 3
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
ACTIVE_NOT_RECRUITING
PHASE3
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
ACTIVE_NOT_RECRUITING
PHASE3
Alternative Approaches for Nausea Control Start of enrollment: 2012 Nov 01
Completed
Not Applicable
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer Start of enrollment: 2014 Jul 22
ACTIVE_NOT_RECRUITING
PHASE3
Join now to see all

Publications & Presentations

PubMed

4 citations
Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates
Usha Malhotra, Sarbajit Mukherjee, Christos Fountzilas, Patrick McKay Boland, Austin Miller
Molecular Cancer Therapeutics. 2020-01-01
6 citations
Positive effects of acupressure bands combined with relaxation music/instructions on patients most at risk for chemotherapy-induced nausea
Anita R. Peoples, Eva Culakova, Charles E. Heckler, Michelle Shayne, Tracey O'Connor
Supportive Care in Cancer. 2019-03-30
13 citations
Racial Differences in Information Needs During and After Cancer Treatment: a Nationwide, Longitudinal Survey by the University of Rochester Cancer Center National Canc...
Matthew Asare, Luke J. Peppone, Joseph A. Roscoe, Ian R. Kleckner, Karen M. Mustian
Journal of Cancer Education. 2018-02-01

Press Mentions

Breast Cancer Study Shows Some Women Can Skip Chemo as Part of Follow-up TreatmentJune 13th, 2018

Professional Memberships

American College of Physicians - ACP
Member
American Society of Clinical Oncology - ASCO
Member